These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
387 related articles for article (PubMed ID: 35298676)
1. Radiomics signature from [ Jiang C; Huang X; Li A; Teng Y; Ding C; Chen J; Xu J; Zhou Z Eur Radiol; 2022 Aug; 32(8):5730-5741. PubMed ID: 35298676 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of metabolic tumour volume on baseline Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463 [TBL] [Abstract][Full Text] [Related]
3. [ Gui J; Li M; Xu J; Zhang X; Mei H; Lan X Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2308-2319. PubMed ID: 38467921 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of a [ Li M; Yao H; Zhang P; Zhang L; Liu W; Jiang Z; Li W; Zhao S; Wang K Eur Radiol; 2023 May; 33(5):3354-3365. PubMed ID: 36547676 [TBL] [Abstract][Full Text] [Related]
5. Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis. Ceriani L; Milan L; Cascione L; Gritti G; Dalmasso F; Esposito F; Pirosa MC; Schär S; Bruno A; Dirnhofer S; Giovanella L; Hayoz S; Mamot C; Rambaldi A; Chauvie S; Zucca E Hematol Oncol; 2022 Feb; 40(1):11-21. PubMed ID: 34714558 [TBL] [Abstract][Full Text] [Related]
6. Development of a radiomic-clinical nomogram for prediction of survival in patients with diffuse large B-cell lymphoma treated with chimeric antigen receptor T cells. Zhou Y; Zhang B; Han J; Dai N; Jia T; Huang H; Deng S; Sang S J Cancer Res Clin Oncol; 2023 Oct; 149(13):11549-11560. PubMed ID: 37395846 [TBL] [Abstract][Full Text] [Related]
7. Survival prediction in diffuse large B-cell lymphoma patients: multimodal PET/CT deep features radiomic model utilizing automated machine learning. Chen J; Lin F; Dai Z; Chen Y; Fan Y; Li A; Zhao C J Cancer Res Clin Oncol; 2024 Oct; 150(10):452. PubMed ID: 39382750 [TBL] [Abstract][Full Text] [Related]
8. Baseline Jing F; Liu Y; Zhao X; Wang N; Dai M; Chen X; Zhang Z; Zhang J; Wang J; Wang Y EJNMMI Res; 2023 Oct; 13(1):92. PubMed ID: 37884763 [TBL] [Abstract][Full Text] [Related]
9. Optimal PET-based radiomic signature construction based on the cross-combination method for predicting the survival of patients with diffuse large B-cell lymphoma. Jiang C; Li A; Teng Y; Huang X; Ding C; Chen J; Xu J; Zhou Z Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2902-2916. PubMed ID: 35146578 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Carlier T; Frécon G; Mateus D; Rizkallah M; Kraeber-Bodéré F; Kanoun S; Blanc-Durand P; Itti E; Le Gouill S; Casasnovas RO; Bodet-Milin C; Bailly C J Nucl Med; 2024 Jan; 65(1):156-162. PubMed ID: 37945379 [TBL] [Abstract][Full Text] [Related]
11. Stacking Ensemble Learning-Based [ Zhao S; Wang J; Jin C; Zhang X; Xue C; Zhou R; Zhong Y; Liu Y; He X; Zhou Y; Xu C; Zhang L; Qian W; Zhang H; Zhang X; Tian M J Nucl Med; 2023 Oct; 64(10):1603-1609. PubMed ID: 37500261 [TBL] [Abstract][Full Text] [Related]
12. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [ Zhang X; Chen L; Jiang H; He X; Feng L; Ni M; Ma M; Wang J; Zhang T; Wu S; Zhou R; Jin C; Zhang K; Qian W; Chen Z; Zhuo C; Zhang H; Tian M Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1298-1310. PubMed ID: 34651227 [TBL] [Abstract][Full Text] [Related]
13. Cui Y; Jiang Y; Deng X; Long W; Liu B; Fan W; Li Y; Zhang X Acad Radiol; 2023 Jul; 30(7):1408-1418. PubMed ID: 36437191 [TBL] [Abstract][Full Text] [Related]
14. Value of Jiang C; Teng Y; Chen J; Wang Z; Zhou Z; Ding C; Xu J Ann Nucl Med; 2020 Dec; 34(12):911-919. PubMed ID: 33057996 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the peripheral blood lymphocyte/monocyte ratio combined with Wu W; Zhao L; Wang Y; Chen P; Yuan X; Miao L; Zhu Y; Mao J; Cai Z; Ji Y; Wang L; Jia T Curr Probl Cancer; 2024 Feb; 48():101066. PubMed ID: 38364336 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Luo Y; Huang Z; Gao Z; Wang B; Zhang Y; Bai Y; Wu Q; Wang M Korean J Radiol; 2024 Feb; 25(2):189-198. PubMed ID: 38288898 [TBL] [Abstract][Full Text] [Related]
17. [Values of Different Evaluation Criteria of Interim Zhu LT; Cen XN; Ou JP; Qiu ZX; Wang LH; Liu W; Wang WS; Dong YJ; Liang ZY; Wang MJ; Xu WL; Sun YH; Wang Q; Yin Y; Ren HY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):431-437. PubMed ID: 28446288 [TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma]. Ding CY; Guo Z; Sun J; Yang WP; Li TR Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362 [No Abstract] [Full Text] [Related]
19. Development and validation of an Wang H; Zhao S; Li L; Tian R Eur Radiol; 2020 Oct; 30(10):5578-5587. PubMed ID: 32435928 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with Guzmán Ortiz S; Mucientes Rasilla J; Vargas Núñez JA; Royuela A; Navarro Matilla B; Mitjavila Casanovas M Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):340-346. PubMed ID: 32646783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]